Pictured: Wendy Lichtenthal
Support
By Andrea Peirce, BA, Writer/Editor  |  Monday, June 23, 2014

Clinical psychologist Wendy Lichtenthal describes the growing recognition that some people suffer from persistent and debilitating grief and may benefit from specific types of help.

Pictured: Peter Allen
In the Clinic
By Jim Stallard, MA, Writer/Editor  |  Wednesday, June 18, 2014

A new drug could make pancreatic surgery safer by reducing the risk of a grave complication.

Pictured: Larry Norton
Video
By Helen Garey, MPH, Freelance Writer  |  Tuesday, June 10, 2014

Memorial Sloan Kettering experts say that new information about the biology of breast cancer is revolutionizing the way they look at the disease.

Pictured: Jedd Wolchok
MSK at ASCO
By Media Staff  |  Wednesday, June 4, 2014

Our experts offer their perspective in major media outlets on recent research into drug- and cell-based immunotherapies for cancer.

Pictured: Helen McArthur
In the Clinic
By Julie Grisham, MS, Science Writer/Editor  |  Tuesday, June 3, 2014

The treatment combines a technique called cryoablation, or freezing of the tumor, with an immunotherapy drug.

Pictured: Jamie Ostroff
On Our Website
By Andrea Peirce, BA, Writer/Editor  |  Friday, May 30, 2014

Become one of the thousands of people that Memorial Sloan Kettering’s Tobacco Treatment Program has helped to quit.

Pictured: David Solit
Profile
By Julie Grisham, MS, Science Writer/Editor  |  Tuesday, May 27, 2014

David Solit, Director of the Marie-Josée and Henry R. Kravis Center for Molecular Oncology, discusses how working with cancer patients drives him to develop more-effective, personalized cancer treatments.

Pictured: Tari King
In the News
By Jennifer Bassett, MA, Writer/Editor  |  Thursday, May 22, 2014

Memorial Sloan Kettering breast surgeon Tari King talks to CBS Online about a new study suggesting double mastectomies may be performed unnecessarily in many women.

Pictured: Mark Kris
Finding
By Julie Grisham, MS, Science Writer/Editor  |  Wednesday, May 21, 2014

A new study has found that driver mutations can be found in about two-thirds of lung adenocarcinomas, suggesting options for treatment with targeted therapies.

pictured: Martin S. Tallman
Profile
By Maureen Salamon, BA, Freelance Writer  |  Monday, May 19, 2014

Leukemia Specialist Martin Tallman discusses how research has led to improvements in the treatment of leukemia and what challenges remain.

Pictured: William Tap
MSK at ASCO
By Media Staff  |  Thursday, May 15, 2014

New Memorial Sloan Kettering research demonstrates the powerful clinical benefit of giving patients a drug that targets the molecular abnormality driving the growth of a rare and debilitating joint disease.

Pictured: Kenneth Offit
Q&A
By Andrea Peirce, BA, Writer/Editor  |  Monday, May 5, 2014

Memorial Sloan Kettering Clinical Genetics Service Chief Kenneth Offit discusses ways for women to clearly assess their risk for breast and ovarian cancers.

Pictured: Jedd Wolchok
In the News
By Jim Stallard, MA, Writer/Editor  |  Friday, May 2, 2014

Memorial Sloan Kettering physician-scientist Jedd Wolchok describes striking advances in cancer immunotherapy in New York Times and Scientific American.

Pictured: Bhuvanesh Singh
Q&A
By Christina Pernambuco-Holsten, MA, Managing Web Editor  |  Friday, April 25, 2014

The HPV vaccine has brought the link between HPV and cervical cancer to the attention of many Americans, but HPV is also behind the fastest-growing type of head and neck cancer in the nation.

In the News
By Jennifer Bassett, MA, Writer/Editor  |  Tuesday, April 22, 2014

Robin Roberts is joined on Good Morning America by Sergio Giralt, Chief of the Adult Bone Marrow Transplantation Service.

Center News

Stay Informed

Get the latest information about cancer care and research every month.